A prospective study on the preventive effect of Qingre Lidan granule on stone recurrence in patients with choledocholithiasis

Phase 1

• Conditions: Choledocholithiasis

• Registration Number: ITMCTR2100004674
• Lead Sponsor: The First Affiliated Hospital of Dalian Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Patients with choledocholithiasis; 2. The patient was over 18 years old; there was no residual stone in the common bile duct after 3.ERCP; 4. The informed consent form was signed by the patient and his family.

Exclusion Criteria

1. Postoperative hepatolithiasis and / or residual stones in the gallbladder; 2. Previous abdominal operations to change the normal anatomical structure of the digestive system, such as stomach, liver, biliary tract and pancreas; 3. Take Qingre Lidan granule allergy; 4. There are contraindications of taking Qingre Lidan granule; 5. Take antiacid drugs such as coleomide (cholestyramine), coratipo (Jiangdanning) and antacid drugs containing aluminum hydroxide and / or montmorillonite (aluminum chloride); 6. Have a history of drinking and taking drugs; 7. Diseases with malignant tumors; 8. Pregnant women, breastfeeding or research period have pregnancy preparation plan; 9. Suffering from severe hepatitis.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Stone recurrence rate after ERCP;Stone recurrence time;

Secondary Outcome Measures

Name	Time	Method
Biochemical liver function index;